Using the AUSDRISK score to screen for pre-diabetes and diabetes in GP practices: a case-finding approach

Aust N Z J Public Health. 2022 Apr;46(2):203-207. doi: 10.1111/1753-6405.13181. Epub 2021 Nov 11.

Abstract

Objective: To identify the optimal AUSDRISK threshold score to screen for pre-diabetes and diabetes.

Methods: A total of 406 adult patients not diagnosed with diabetes were screened in General Practices (GP) between May and October 2019. All patients received a point of care (POC) HbA1c test. HbA1c test results were categorised into diabetes (≥6.5% or ≥48 mmol/mol), pre-diabetes (5.7-6.4% or 39-47 mmol/mol), or normal (<5.7% or 39 mmol/mol).

Results: Of these patients, 9 (2%) had undiagnosed diabetes and 60 (15%) had pre-diabetes. A Receiver Operator Characteristic (ROC) curve was constructed to predict the presence of pre-diabetes and diabetes; the area under the ROC curve was 0.72 (95%CI 0.65-0.78) indicating modest predictive ability. The optimal threshold cut point for AUSDRISK score was 17 (sensitivity 76%, specificity 61%, + likelihood ratio (LR) 1.96, - likelihood ratio of 0.39) while the accepted cut point of 12 performed less well (sensitivity 94%, specificity 23%, +LR=1.22 -LR+0.26).

Conclusions: The AUSDRISK tool has the potential to be used as a screening tool for pre-diabetes/diabetes in GP practices. A cut point of ≥17 would potentially identify 75% of all people at risk and three in 10 sent for further testing would be positive for prediabetes or diabetes.

Implications for public health: Routine case-finding in high-risk patients will enable GPs to intervene early and prevent further public health burden from the sequelae of diabetes.

Keywords: AUSDRISK; diabetes; pre-diabetes; prevention; primary care.

MeSH terms

  • Adult
  • Blood Glucose
  • Diabetes Mellitus* / diagnosis
  • Diabetes Mellitus* / epidemiology
  • Diabetes Mellitus, Type 2* / diagnosis
  • Diabetes Mellitus, Type 2* / epidemiology
  • Humans
  • Mass Screening / methods
  • Prediabetic State* / diagnosis
  • Prediabetic State* / epidemiology
  • Sensitivity and Specificity

Substances

  • Blood Glucose